drugset / Trial / NCT05951400
Progesterone Primed Protocol Versus GnRH Antagonist in With PCO Undergoing ICSI
RandomizedParallel-groupOpen-labelTreatment
Summary
To compare the effectiveness and safety of Progesterone Primed Ovarian Stimulation protocol (PPOS) using Dydrogestrone vs GnRH Antagonist Protocol in patients with expected high ovarian response undergoing ICSI cycle
Timeline
- Start
- 2024-01-01
- Primary completion
- 2026-03-30
- Completion
- 2026-04-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Cetrorelix | Other / unclassified | 0.25 mg | Subcutaneous |
| Subject | Dydrogesterone | Other / unclassified | 30 mg | Oral |
Indications
No indication recorded.